[The potentials of combined chemotherapy in disseminated ovarian cancer].
Gorbunova
V A
VA
Perevodchikova
N I
NI
Kozachenko
V P
VP
Ryzhakov
V M
VM
Marenich
A F
AF
Zhordania
K I
KI
D006585:Altretamine / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D012074:Remission Induction
D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin; D006585:Altretamine
Vozmozhnosti kombinirovannoĭ khimioterapii rasprostranennogo raka iaichnikov.